These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A study of four anti-streptococcal antibodies in rheumatic fever and diseases related with streptococci in childhood]. Miyazaki H Igaku Kenkyu; 1985 Dec; 55(4):200-25. PubMed ID: 3837975 [No Abstract] [Full Text] [Related]
5. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S; Faulkner L; Hopkins P Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999 [TBL] [Abstract][Full Text] [Related]
6. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome. Schrage B; Duan G; Yang LP; Fraser JD; Proft T Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. Yarwood JM; Leung DY; Schlievert PM FEMS Microbiol Lett; 2000 Nov; 192(1):1-7. PubMed ID: 11040420 [TBL] [Abstract][Full Text] [Related]
8. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Smoot LM; McCormick JK; Smoot JC; Hoe NP; Strickland I; Cole RL; Barbian KD; Earhart CA; Ohlendorf DH; Veasy LG; Hill HR; Leung DY; Schlievert PM; Musser JM Infect Immun; 2002 Dec; 70(12):7095-104. PubMed ID: 12438391 [TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease and toxic shock syndrome--at last the etiology is clear? Curtis N Adv Exp Med Biol; 2004; 549():191-200. PubMed ID: 15250533 [TBL] [Abstract][Full Text] [Related]
10. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628 [TBL] [Abstract][Full Text] [Related]
11. Toxin-mediated streptococcal and staphylococcal disease. Manders SM J Am Acad Dermatol; 1998 Sep; 39(3):383-98; quiz 399-400. PubMed ID: 9738772 [TBL] [Abstract][Full Text] [Related]
12. Group A Streptococcus virulence and host factors in two toddlers with rheumatic fever following toxic shock syndrome. Smeesters PR; Drèze PA; Perez-Morga D; Biarent D; Van Melderen L; Vergison A Int J Infect Dis; 2010 May; 14(5):e403-9. PubMed ID: 19828348 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. Leung DY; Travers JB; Giorno R; Norris DA; Skinner R; Aelion J; Kazemi LV; Kim MH; Trumble AE; Kotb M J Clin Invest; 1995 Nov; 96(5):2106-12. PubMed ID: 7593594 [TBL] [Abstract][Full Text] [Related]
14. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684 [TBL] [Abstract][Full Text] [Related]
15. Superantigens and their role in infectious disease. Schafer R; Sheil JM Adv Pediatr Infect Dis; 1995; 10():369-90. PubMed ID: 7718212 [TBL] [Abstract][Full Text] [Related]
16. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. Schlievert PM J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S107-10. PubMed ID: 11586276 [TBL] [Abstract][Full Text] [Related]
17. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Sriskandan S; Moyes D; Cohen J Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404 [No Abstract] [Full Text] [Related]
18. [The role of superantigens in infectious diseases]. Santolaya ME Rev Med Chil; 1998 Jul; 126(7):846-54. PubMed ID: 9830779 [TBL] [Abstract][Full Text] [Related]
19. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429 [TBL] [Abstract][Full Text] [Related]